Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial Fibrillation
Jump to

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: Genome-wide association studies have identified 23 loci for atrial fibrillation (AF), but the mechanisms responsible for these associations, as well as the causal genes and genetic variants, remain undefined.
Methods: To identify the effect of common genetic variants on gene expression that might explain the mechanisms linking genome-wide association loci with AF risk, we performed RNA sequencing of left atrial appendages from a biracial cohort of 265 subjects.
Results: Combining gene expression data with genome-wide single nucleotide polymorphism data, we found that approximately two-thirds of the expressed genes were regulated in cis by common genetic variants at a false discovery rate of <0.05, defined as cis-expression quantitative trait loci. Twelve of 23 reported AF genome-wide association loci displayed genome-wide significant cis-expression quantitative trait loci, at PRRX1 (chromosome 1q24), SNRNP27 (1q24), CEP68 (2p14), FKBP7 (2q31), KCNN2 (5q22), FAM13B (5q31), CAV1 (7q31), ASAH1 (8p22), MYOZ1 (10q22), C11ORF45 (11q24), TBX5 (12q24), and SYNE2 (14q23), suggesting that altered expression of these genes plays a role in AF susceptibility. Allelic expression imbalance was used as an independent method to characterize the cis-control of gene expression. One thousand two hundred forty-eight of 5153 queried genes had cis-single nucleotide polymorphisms that significantly regulated allelic expression at a false discovery rate of <0.05.
Conclusions: We provide a genome-wide catalog of the genetic control of gene expression in human left atrial appendage. These data can be used to confirm the relevance of genome-wide association loci and to direct future functional studies to identify the genes and genetic variants responsible for complex diseases such as AF.
- Received March 7, 2017.
- Accepted January 23, 2018.
- © 2018 American Heart Association, Inc.
American Heart Association Professional?
Log in using your username and password
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
This Issue
Jump to
Article Tools
- Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial FibrillationJeffrey Hsu, Shamone Gore-Panter, Gregory Tchou, Laurie Castel, Beth Lovano, Christine S. Moravec, Gosta B. Pettersson, Eric E. Roselli, A. Marc Gillinov, Kenneth R. McCurry, Nicholas G. Smedira, John Barnard, David R. Van Wagoner, Mina K. Chung and Jonathan D. SmithCirc Genom Precis Med. 2018;11:e002107, originally published March 15, 2018https://doi.org/10.1161/CIRCGEN.118.002107
Citation Manager Formats
Share this Article
- Genetic Control of Left Atrial Gene Expression Yields Insights into the Genetic Susceptibility for Atrial FibrillationJeffrey Hsu, Shamone Gore-Panter, Gregory Tchou, Laurie Castel, Beth Lovano, Christine S. Moravec, Gosta B. Pettersson, Eric E. Roselli, A. Marc Gillinov, Kenneth R. McCurry, Nicholas G. Smedira, John Barnard, David R. Van Wagoner, Mina K. Chung and Jonathan D. SmithCirc Genom Precis Med. 2018;11:e002107, originally published March 15, 2018https://doi.org/10.1161/CIRCGEN.118.002107